Speaker Profile
M.D., Ph.D., ASSISTANT PROFESSOR OF MEDICINE (ONCOLOGY), Stanford
Biography
Dr. Betof Warner is a boardcertified medical oncologist specializing in advanced melanoma treatment. She serves as the Director of Melanoma Medical Oncology, Director of Solid Tumor Cellular Therapy, and coDirector of the Pigmented Lesion and Melanoma Program. A pioneer in tumor infiltrating lymphocyte (TIL) therapy, she leads the Melanoma Cutaneous Oncology Clinical Research Group, focusing on tumor response to immunotherapy. Recognized for her expertise in central nervous system metastases and novel cellular therapies, she's collaborated globally and received accolades from ASCO, NIH, and the Melanoma Research Foundation. Dr. Betof Warner is an active member of several professional organizations, including the American Association for Cancer Research and the Society for Immunotherapy of Cancer.
Session Abstract – PMWC 2024 Silicon Valley
Track Chair: Sharon Benzeno, Adaptive Biotechnologies
- PMWC 2024 Award Ceremony
Pioneer Honoree: Stanley Riddell, Fred Hutchinson
Pioneer Honoree: George Coukos, Ludwig Cancer Center
- Discovery of Novel Targets in Cell Therapies in Oncology and Autoimmune Disorders (PANEL)
Chair: Harlan Robins, Adaptive Bio
- Stanley Riddell, Fred Hutchinson
- Allison Betof Warner, Stanford - Evolving Case Law and Practical Strategies for Immunotherapy Patents
- Janet Xiao, Morrison & Foerster LLP
- Scientific Advancements in Individualized Cell Therapeutics for Oncology( PANEL)
Chair: Sharon Benzeno, Adaptive Biotechnologies
- Ira Mellman, Genenetch
- George Coukos, Ludwig Institute for Cancer Research
- Bobert Meehan, Moderna - Supply Chain 2.0 Getting Cell Therapies to Patients (PANEL)
Chair: TBA
- Amanda Pace, Sonoma Bio - AI-Enhanced Approaches in Gene-Modified Cell Therapy Development
Chair: TBA
- Brian Weitzner, Outpace Bio
- Richard Bonneau, Prescient Design
